<ul><li>Colombian startup Salva Health aims to lower breast cancer mortality rates in Latin America.</li><li>The company developed Julietta, a portable device that measures tissue density and provides results within minutes.</li><li>Salva Health partnered with Grupo Sura to conduct clinical trials and develop an AI model for predicting breast cancer risk.</li><li>After receiving approval from Colombia’s INVIMA, Salva plans to distribute Julietta throughout Latin America and expand to other emerging markets.</li></ul>

Salva Health wants to lower breast cancer mortality with its affordable screening device

Discover more